Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Farnesoid X nuclear receptor ligand obeticholic acid for ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
0
Authors
Brent Neuschwander‐Tetri
17 more
Brent Neuschwander‐Tetri
•
Anna Diehl
15 more
•
Edward Doo
Published
November 7, 2014
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Epidemiology
Show all topics
DOI
10.1016/s0140-6736(14)61933-4
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Chemistry
Biochemistry
Medicine
Cancer Oncology
Epidemiology
Show all topics
DOI
10.1016/s0140-6736(14)61933-4
Other Formats
PDF
